Managing food allergy in childhood
aDivision of Rheumatology, Allergy and Immunology, Department of Medicine bDepartment of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Current opinion in pediatrics
(Impact Factor: 2.53).
08/2012; 24(5):615-20. DOI: 10.1097/MOP.0b013e32835741e3
This study reviews the newest developments on experimental therapies for the treatment of food allergy.
Epitope studies and microarray technology promise to improve the accuracy of diagnostic testing and may allow the prediction of reaction severity and the likelihood of allergy resolution. The regular ingestion of small amounts of food in oral immunotherapy (OIT) has been shown to dramatically increase reaction thresholds. However, a subset of patients have developed significant gastrointestinal symptoms requiring discontinuation of the treatment. A similar treatment given sublingually has appeared safer than OIT, but has also shown a less robust effect. Ingestion of extensively heated foods seems to accelerate the natural resolution of milk and egg allergy. The injectable anti-IgE therapy omalizumab has been shown to benefit in conjunction with OIT and preliminary data has suggested that it may also be effective as monotherapy. The Chinese herbal formula FAHF-2 has been shown to suppress anaphylaxis from single and multiple food allergies in mice, and early human studies have shown that it is well tolerated.
Improved testing should allow more accurate diagnosis of food allergy. For these patients, treatments are on the horizon, but further studies are needed to determine long-term safety and efficacy.
Available from: Kyoko Sudo
- "Most previous standardized protocols involve multiple dose increasing phase at an initial day or several days, termed as a rush escalation phase, which is either performed in an outpatient clinic or in a hospital, followed by a more gradual weekly to biweekly dose escalation period at home [1,12,24-27]. Although this approach greatly contributes to desensitization and potential permanent tolerance for patients with food allergies, adverse events occur mainly during the rush escalation phase. "
[Show abstract] [Hide abstract]
ABSTRACT: Home based oral immunotherapy (OIT) for food allergy has often been used for young children in Japan, the majority of whom are believed to outgrow the allergy by the school age, therefore the true efficacy of the therapy has been controversial. The aim of this study was to evaluate the efficacy and safety of a newly developed slow- type home-based oral immunotherapy (OIT) regimen in children with hen's egg (HE) allergy, who had low likelihood of outgrowing the allergy, with treatment involving only elimination diet.
We retrospectively reviewed the medical records of 43 children with egg allergy (30 males; median age 6) who fulfilled Burks et al.'s criteria of being unlikely to outgrow the allergy. Thirty children who agreed to start OIT were assigned to the treatment group, and 13 who did not want to participate immediately were assigned to the untreated group; the patients underwent an elimination diet for 1 year, during which they were monitored. The OIT regimen involved the intake of the maximum tolerated dose 2 to 3 times a week at home, with initial dose introduction followed by dose build-ups with medical supervision. We statistically evaluated the rate of children who changed their threshold up to 32 g of egg - defined as, oral tolerance induction- in both the groups for 1 year and in the OIT group for 2 years, as well as the rate of children who fulfilled Savage et al.'s criteria of clinical tolerance after reaching the abovementioned remission stage.
The rate of children who achieved oral tolerance induction to 32 g of egg after 1 year in the OIT group (9/30) was significantly higher than that in the untreated group (0/13). The total rate within the OIT group was significantly increased from 9/30 at 1 year to 17/30 at two years without any severe adverse reaction; of the above 17 children, we followed 14 children, and noted that 11 of these were able to obtain clinical tolerance.
The home-based OIT with an intermittent loading protocol was very safe and effective in children with a low likelihood of outgrowing egg allergy.
Allergy Asthma and Clinical Immunology 02/2014; 10(1):11. DOI:10.1186/1710-1492-10-11 · 2.03 Impact Factor
Available from: Nelson A Rosário
The Journal of allergy and clinical immunology 03/2013; 132(1). DOI:10.1016/j.jaci.2013.01.033 · 11.48 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.